Clinical endocrinology · 2025
Genotype-Phenotype Correlation in Germline TSH Receptor Activating Mutation Associated Hyperthyroidism: A Systematic Review.
СтатьяСистематический обзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yamichannaiah Chethan, Memon Saba Samad, Sarathi Vijaya, Lila Anurag Ranjan, Jadhav Swati Ramteke, Thadani Puja, Hegishte Samiksha Chandrashekhar, Barnabas Rohit, Karlekar Manjiri, Phadte Aditya, Sharma Anima, Bandgar Tushar
Аннотация
OBJECTIVE: Germline TSHR activating mutation-associated hyperthyroidism (GTAMH) manifests as sporadic or familial forms. Studies have shown poor correlation between receptor activity and clinical manifestations, highlighting a knowledge gap in understanding genotype-phenotype relationships.
DESIGN: A classification based on age of symptom onset: infantile (n = 36), childhood (n = 33) and adulthood (> 18 years, n = 13) was attempted by performing a systematic review of literature of GTAMH (n = 82 probands, including a 25-year-old woman with TSHR p.Ile640Val variant and subclinical hyperthyroidism managed at our centre). Patients were analysed for various parameters such as demographic, clinical, biochemical and genotype-phenotype correlation.
RESULTS: Eighty-two probands harbouring 47 different TSHR variants are reported. Probands with infantile-onset were less often familial (19.4%, p = 0.00) than childhood (93.9%) and adult-onset (84.6%) cases. Median serum free-T3 and T4 were highest in infantile (3.1 and 3.4 XULN) followed by childhood (1.6 and 1.9 X-ULN) and adult-onset (1.2 and 0.8 X-ULN) cases. All infant/childhood onset probands had overt hyperthyroidism, whereas 1/3 of adult-onset cases were subclinical. Most (15/18) recurrent variants were exclusive to infantile, childhood or adult-onset disease groups, except for p.Ser505Asn, p.Asp619Gly and p.Asn670Ser. Including data for probands and genetically affected family members, there was a moderate correlation for the age at diagnosis (infancy, childhood or adulthood), among family members (r = 0.40, p = 0.00), and members of multiple families harbouring the same TSHR variants (r = 0.46, p = 0.00).
CONCLUSION: A phenotypic classification of GTAMH into infantile-onset severe hyperthyroxinemia (mostly due to de novo variants), childhood-onset overt hyperthyroidism or adulthood-onset overt/subclinical hyperthyroidism correlates with the genotype of TSHR variants, may guide patient management.
DESIGN: A classification based on age of symptom onset: infantile (n = 36), childhood (n = 33) and adulthood (> 18 years, n = 13) was attempted by performing a systematic review of literature of GTAMH (n = 82 probands, including a 25-year-old woman with TSHR p.Ile640Val variant and subclinical hyperthyroidism managed at our centre). Patients were analysed for various parameters such as demographic, clinical, biochemical and genotype-phenotype correlation.
RESULTS: Eighty-two probands harbouring 47 different TSHR variants are reported. Probands with infantile-onset were less often familial (19.4%, p = 0.00) than childhood (93.9%) and adult-onset (84.6%) cases. Median serum free-T3 and T4 were highest in infantile (3.1 and 3.4 XULN) followed by childhood (1.6 and 1.9 X-ULN) and adult-onset (1.2 and 0.8 X-ULN) cases. All infant/childhood onset probands had overt hyperthyroidism, whereas 1/3 of adult-onset cases were subclinical. Most (15/18) recurrent variants were exclusive to infantile, childhood or adult-onset disease groups, except for p.Ser505Asn, p.Asp619Gly and p.Asn670Ser. Including data for probands and genetically affected family members, there was a moderate correlation for the age at diagnosis (infancy, childhood or adulthood), among family members (r = 0.40, p = 0.00), and members of multiple families harbouring the same TSHR variants (r = 0.46, p = 0.00).
CONCLUSION: A phenotypic classification of GTAMH into infantile-onset severe hyperthyroxinemia (mostly due to de novo variants), childhood-onset overt hyperthyroidism or adulthood-onset overt/subclinical hyperthyroidism correlates with the genotype of TSHR variants, may guide patient management.